MCDTR Center Overview Abstract The Michigan Center for Diabetes Translational Research (MCDTR) supports MCDTR members and regional, national, and international collaborators to conduct research to translate diabetes interventions with proven efficacy from the bedside into clinical and community practice (type 2 translational research).
The specific aims of the MCDTR are to: ? Raise awareness of, and interest in, type 2 translational research in diabetes and create an environment that supports such research ? Identify, develop, and support researchers engaged in research to translate interventions with proven efficacy into real world health care settings, communities, and populations at risk ? Administer cores that provide services critical to type 2 translational research in diabetes for new and established investigators ? Foster interdisciplinary collaborations to advance type 2 translational research in diabetes ? Provide education and training opportunities in diabetes translational research ? Administer a Pilot and Feasibility Study Grants Program to attract new investigators to the field and to enable them to generate preliminary data for successful grant applications The Center supports four cores. The Administration Core maintains the MCDTR Research Base and is responsible for the direction, functioning, and finances of the Center. It administers the Pilot and Feasibility Study Grants Program and the Enrichment Program and maintains the MCDTR website. The Methods and Measurement Core focuses on design and analysis issues in translational research (including health economics). The Intervention and Technology Research Core focuses on technology-based approaches to intervention delivery, health communication, and peer support. The Community Outreach and Engagement Core focuses on community engagement, intervention implementation and dissemination with special focus on patient empowerment, cultural competence, health disparities, implementation science research, and community-based participatory research.

Public Health Relevance

MCDTR Center Overview Project Narrative Over the past two decades, clinical trials have established the scientific basis for diabetes prevention and control. Nevertheless, large gaps remain between optimal diabetes care and the care delivered in routine clinical practice. The purpose of the Michigan Center for Diabetes Translational Research (MCDTR) is to provide shared resources to foster productivity, synergy, and new research ideas among funded investigators to test innovative adaptations of evidence-based approaches to diabetes prevention and control that can be disseminated to positively impact clinical and community practice outside the traditional academic research environment. The Center also provides Enrichment and Pilot and Feasibility Study Grants Programs to attract, develop, and retain new investigators in the field of type 2 translational research in diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK092926-09
Application #
9782893
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Thornton, Pamela L
Project Start
2011-09-06
Project End
2021-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
9
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Govani, Shail M; Noureldin, Mohamed; Higgins, Peter D R et al. (2018) Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases. Am J Gastroenterol 113:276-282
Kuo, Shihchen; Yang, Chun-Ting; Wu, Jin-Shang et al. (2018) Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study. Diabetes Obes Metab :
Sjoding, Michael W; Hofer, Timothy P; Co, Ivan et al. (2018) Interobserver Reliability of the Berlin ARDS Definition and Strategies to Improve the Reliability of ARDS Diagnosis. Chest 153:361-367
Hedgeman, Elizabeth; Hasson, Rebecca E; Karvonen-Gutierrez, Carrie A et al. (2018) Perceived stress across the midlife: longitudinal changes among a diverse sample of women, the Study of Women's health Across the Nation (SWAN). Womens Midlife Health 4:
Pesch, Megan H; Miller, Alison L; Appugliese, Danielle P et al. (2018) Mothers of Obese Children Use More Direct Imperatives to Restrict Eating. J Nutr Educ Behav 50:403-407.e1
Batch, Bryan C; Goldstein, Karen; Yancy Jr, William S et al. (2018) Outcome by Gender in the Veterans Health Administration Motivating Overweight/Obese Veterans Everywhere Weight Management Program. J Womens Health (Larchmt) 27:32-39
Ge, Chunxi; Zhao, Guisheng; Li, BinBin et al. (2018) Genetic inhibition of PPAR? S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis. Bone 107:1-9
Jaiswal, Mamta; Divers, Jasmin; Pop-Busui, Rodica et al. (2018) Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226-1232. Diabetes Care 41:e37
Lisabeth, Lynda D; Baek, Jonggyu; Morgenstern, Lewis B et al. (2018) Prognosis of Midlife Stroke. J Stroke Cerebrovasc Dis 27:1153-1159
Buras, Eric D; Weatherup, Emily; Wyckoff, Jennifer (2018) Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma. Clin Diabetes Endocrinol 4:2

Showing the most recent 10 out of 592 publications